Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 18, 2026 09:00 ET | Source: WidePoint Corporation

WidePoint Corporation Announces $1.3 Million Managed Services Win with Leading Beverage Bottler

WidePoint announces a phase one $1.3 million contract award to its Managed Services division with one of the leading bottlers in the beverage industry.
February 17, 2026 06:00 ET | Source: Teva Pharmaceutical Industries Ltd

Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease

In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had responded after 14 weeks of inductionDuvakitug was well...
February 17, 2026 06:00 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse : Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva ont démontré une efficacité durable cliniquement significative dans la colite ulcéreuse et la maladie de Crohn

Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva ont démontré une efficacité durable cliniquement significative dans la colite ulcéreuse et la maladie de Crohn Dans...
February 17, 2026 06:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease

Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease In the RELIEVE UCCD LTE phase 2b study, duvakitug...
February 02, 2026 10:00 ET | Source: Dermatology Times

MJH Life Sciences® announces new era in dermatology NP/PA education and engagement

MJH Life Sciences launches Dermatology Times NP/PA Connect and CME meetings to advance dermatology NP/PA education.
January 21, 2026 03:05 ET | Source: CallTower, Inc.

CallTower adds secure and affordable WhatsApp comms for employees, customers and businesses of all sizes

LONDON, SALT LAKE CITY, UT, ROCHESTER, NY, MONTREAL, QC, Jan. 21, 2026 (GLOBE NEWSWIRE) -- CallTower, a global leader in unified communications, contact centre, and collaboration solutions, has...
January 06, 2026 03:05 ET | Source: CallTower, Inc.

CallTower Wins 2025 BIG Awards for Business for Operator Connect for Microsoft Teams

SALT LAKE CITY, UT, ROCHESTER, NY, MONTREAL, QC, LONDON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- CallTower, a global leader in unified communications and contact center solutions, today announced that...
January 05, 2026 07:20 ET | Source: Precedence Research

Maternal Nutrition Market Size to Surpass USD 70.36 Billion by 2035, Driven by Preventive Healthcare and AI-Led Innovation

Ottawa, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The global maternal nutrition market size stood at USD 33.20 billion in 2025 and is predicted to grow from USD 35.79 billion in 2026 to reach around USD...
November 27, 2025 12:00 ET | Source: MCI, LC

MCI Taps FEMA/DHS Veteran Executive Mark Misczak as President; Spins Out Tier-5 AiCX.com Division

CX CONGLOMERATE MCI TAPS FEMA/DHS VETERAN EXECUTIVE MARK MISCZAK AS PRESIDENT; SPINS OUT TIER-5 AiCX.COM DIVISION
November 10, 2025 09:00 ET | Source: AnaptysBio, Inc.

Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis

Rosnilimab was safe and well tolerated with similar adverse event rates vs. placeboObserved expected pharmacology, including ~90% depletion of pathogenic T cells, however lack of adequate efficacy at...